Recherche
-
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueLibre accès -
Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort
(Journal of the International AIDS Society. vol. 19, n° 1, 2016-02-08)Article de revueLibre accès -
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection
(Plos Pathogens. vol. 15, n° 5, pp. e1007758, 2019-05-16)Article de revueLibre accès -
Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial
(Journal of Cachexia, Sarcopenia and Muscle. vol. 10, n° 2, pp. 287-297, 2019)Article de revueLibre accès -
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
(Journal of Immunology. vol. 208, n° 12, pp. 2663-2674, 2022-06-15)Article de revue -
Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach
(Computational Statistics, 2023-10-14)Article de revueLibre accès -
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
(iScience. vol. 24, n° 7, pp. 102711, 2021-07-23)Article de revueLibre accès -
The French Covid-19 contact tracing app: knowledge, attitudes, beliefs and practices of students in the health domain
(Journal of Medical Internet Research. vol. 23, n° 3, pp. e26399, 2021-03-03)Article de revueLibre accès -
A machine learning approach for predicting suicidal thoughts and behaviours among college students
(Scientific Reports. vol. 11, n° 1, pp. 11363, 2021-06-15)Article de revueLibre accès -
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
(European Radiology, 2023-07-05)Article de revueLibre accès